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Aim: To develop a patient-specific intelligent tool for predicting risk levels of diabetic neuropathy 
depending on the risk factors.   
 
Methods: Vibration perception threshold (VPT) measured using a Neurothesiometer to identify the 
level of diabetic neuropathy and potential VPT predictors were obtained from a clinical database (n = 
5088). A regression model was used to identify significant predictors of VPT. Predictors were 
linearised using a Box-Cox transformation, and VPT was log transformed to reduce skewness. To 
provide data with properties similar to the patient data but with improved precision, 4159 cases 
were simulated with patient means and covariance’s but with reduced standard errors. A Neural 
Network based on a Proportional Odds Model (NNPOM) was trained using the patient data set as 
well as the simulated patient data set where VPT in Volts (V) was encoded into three categories low 
risk (0 to 20.99 V), medium risk (21 to 30.99 V) and high risk (≥ 31 V). 
 
Results: Age, height, weight, HbA1c, cholesterol and duration of diabetes were identified as the 
major risk factors of diabetic neuropathy. The proposed method was applied for the prediction of 
VPT risk categories. The NNPOM achieved an accuracy of 54 % on real patient data and 68 % on 
simulated patient data.  
 
Conclusion: The results show that increased predictor precision improves classification success. 
Using this neural network trained model, risk assessment tool was developed for VPT prediction with 
moderate accuracy in terms of diabetic neuropathy risk levels based on clinical history of the 
subject.  
 
